Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics
Abstract
:1. Epidemiology, Microbiology, and Transmission
2. Clinical Manifestations
Complications
3. Diagnosis
3.1. Direct Visualization of the Amastigote
3.2. Culture
3.3. Serological Assays and Rapid Diagnostic Tests (RDTs)
3.4. Polymerase Chain Reaction (PCR) Tests
3.5. Other Tests
3.6. Diagnostic Approach
4. Therapy
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wang, H.; Naghavi, M.; Allen, C.; Barber, R.M.; Carter, A.; Casey, D.C.; Charlson, F.J.; Chen, A.Z.; Coates, M.M.; Coggeshall, M.; et al. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1459–1544. [Google Scholar] [CrossRef]
- GBD 2017 DALYs and HALE Collaborators. Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 359 Diseases and Injuries and Healthy Life Expectancy (HALE) for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017; Elsevier: Amsterdam, The Netherlands, 2018; Volume 392, pp. 1859–1922. [Google Scholar] [CrossRef]
- Pacheco-Fernandez, T.; Volpedo, G.; Gannavaram, S.; Bhattacharya, P.; Dey, R.; Satoskar, A.; Matlashewski, G.; Nakhasi, H.L. Revival of Leishmanization and Leishmanin. Front. Cell. Infect. Microbiol. 2021, 11, 639801. [Google Scholar] [CrossRef] [PubMed]
- Yamey, G. The World’s Most Neglected Diseases. Br. Med. J. 2002, 325, 176–177. [Google Scholar] [CrossRef] [PubMed]
- Murray, H. Kala-Azar—Progress against a Neglected Disease. N. Engl. J. Med. 2002, 145, 127–145. [Google Scholar] [CrossRef] [PubMed]
- Ruiz-Postigo, J.A.; Jain, S.; Mikhailov, A.; Maia-Elkhoury, A.N.; Valadas, S.; Warusavithana, S.; Osman, M. Global Leishmaniasis Surveillance: 2019–2020, a Baseline for the 2030 Roadmap. Wkly. Epidemiol. Rec. 2021, 96, 401–420. [Google Scholar]
- Burza, S.; Croft, S.L.; Boelaert, M. Leishmaniasis. Lancet 2018, 392, 951–970. [Google Scholar] [CrossRef]
- van Griensven, J.; Diro, E. Visceral Leishmaniasis. Infect. Dis. Clin. North Am. 2012, 26, 309–322. [Google Scholar] [CrossRef]
- While, C.; Resolution, W.; Sixtieth, W.; Health, A. Global Leishmaniasis Surveillance Le Point Sur La Situation Mondiale de La Leishmaniose, 1998–2016. Wkly. Epidemiol. Rec. 2018, 93, 530–540. [Google Scholar]
- Varani, S.; Cagarelli, R.; Melchionda, F.; Attard, L.; Salvadori, C.; Finarelli, A.C.; Gentilomi, G.A.; Tigani, R.; Rangoni, R.; Todeschini, R.; et al. Ongoing Outbreak of Visceral Leishmaniasis in Bologna Province, Italy, November 2012 to May 2013. Eurosurveillance 2013, 18, 20530. [Google Scholar] [CrossRef]
- Dujardin, J.C.; Campino, L.; Cañavate, C.; Dedet, J.P.; Gradoni, L.; Soteriadou, K.; Mazeris, A.; Ozbel, Y.; Boelaert, M. Spread of Vector-Borne Diseases and Neglect of Leishmaniasis, Europe. Emerg. Infect. Dis. 2008, 14, 1013–1018. [Google Scholar] [CrossRef]
- Berriatua, E.; Jumakanova, Z.; Munoz, C.; Ortuno, M.; Perez-Cutillas, P.; Monge-Maillo, B.; Conceição, C.; Maia, C.; Pereira, A.; Rocha, R.; et al. Surveillance, Prevention and Control of Leishmaniases in the European Union and Its Neighbouring Countries; ECDC: Stockholm, Sweden, 2022; ISBN 9789294985729. [Google Scholar]
- Bern, C.; Hightower, A.W.; Chowdhury, R.; Ali, M.; Amann, J.; Wagatsuma, Y.; Haque, R.; Kurkjian, K.; Vaz, L.E.; Begum, M.; et al. Risk Factors for Kala-Azar in Bangladesh. Emerg. Infect. Dis. 2005, 11, 655–662. [Google Scholar] [CrossRef] [PubMed]
- Arce, A.; Estirado, A.; Ordobas, M.; Sevilla, S.; García, N.; Moratilla, L.; de la Fuente, S.; Martínez, A.M.; Pérez, A.M.; Aránguez, E.; et al. Re-Emergence of Leishmaniasis in Spain: Community Outbreak in Madrid, Spain, 2009 TO 2012. Eurosurveillance 2013, 18, 20546. [Google Scholar] [CrossRef] [PubMed]
- Aronson, N.; Herwaldt, B.L.; Libman, M.; Pearson, R.; Lopez-Velez, R.; Weina, P.; Carvalho, E.M.; Ephros, M.; Jeronimo, S.; Magill, A. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin. Infect. Dis. 2016, 63, 1539–1557. [Google Scholar] [CrossRef] [PubMed]
- Singh, O.P.; Hasker, E.; Sacks, D.; Boelaert, M.; Sundar, S. Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control. Clin. Infect. Dis. 2014, 58, 1424–1429. [Google Scholar] [CrossRef] [PubMed]
- Maxfield, L.; Crane, J.S. Leishmaniasis. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2022. Available online: https://www.ncbi.nlm.nih.gov/books/NBK531456/ (accessed on 16 September 2022).
- World Health Organization. Leishmaniasis in High-Burden Countries: An Epidemiological Update Based on Data Reported in 2014. Wkly. Epidemiol. Rec. 2016, 91, 287–296. [Google Scholar]
- Bern, C.; Maguire, J.H.; Alvar, J. Complexities of Assessing the Disease Burden Attributable to Leishmaniasis. PLoS Negl. Trop. Dis. 2008, 2, e313. [Google Scholar] [CrossRef]
- Pace, D. Leishmaniasis. J. Infect. 2014, 69, S10–S18. [Google Scholar] [CrossRef]
- Safavi, M.; Eshaghi, H.; Hajihassani, Z. Visceral Leishmaniasis: Kala-Azar. Diagn. Cytopathol. 2021, 49, 446–448. [Google Scholar] [CrossRef]
- Molina, R.; Jiménez, M.I.; Cruz, I.; Iriso, A.; Martín-Martín, I.; Sevillano, O.; Melero, S.; Bernal, J. The Hare (Lepus Granatensis) as Potential Sylvatic Reservoir of Leishmania Infantum in Spain. Vet. Parasitol. 2012, 190, 268–271. [Google Scholar] [CrossRef]
- Jiménez, M.; González, E.; Martín-Martín, I.; Hernández, S.; Molina, R. Could Wild Rabbits (Oryctolagus Cuniculus) Be Reservoirs for Leishmania Infantum in the Focus of Madrid, Spain? Vet. Parasitol. 2014, 202, 296–300. [Google Scholar] [CrossRef]
- Rather, S.; Yaseen, A.; Shah, F.Y.; Wani, M.; Krishan, K.; Zirak, S.; Sharma, R.; Hassan, I.; Dogra, D. Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India. Indian Dermatol. Online J. 2022, 12, 852–859. [Google Scholar] [CrossRef] [PubMed]
- Kimberlin, D.W.; Barnett, E.D.; Lynfield, R.; Sawyer, M. Red Book: 2021 Report of the Committee on Infectious Diseases; American Academy of Pediatrics: Itasca, IL, USA, 2003; ISBN 9781610020602. [Google Scholar]
- Herwaldt, B.L. Leishmaniasis. Lancet 1999, 354, 1191–1199. [Google Scholar] [CrossRef] [Green Version]
- Melchionda, F.; Varani, S.; Carfagnini, F.; Belotti, T.; Di Muccio, T.; Tigani, R.; Bergamaschi, R.; Pession, A. Spleen Nodules: A Potential Hallmark of Visceral Leishmaniasis in Young Children. BMC Infect. Dis. 2014, 14, 620. [Google Scholar] [CrossRef]
- Varma, N.; Naseem, S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian J. Hematol. Blood Transfus. 2010, 26, 78–82. [Google Scholar] [CrossRef]
- Al-jurayyan, N.A.M.; Al-nasser, M.N.; Al-fawaz, I.M.; Al Ayed, I.H.; Al Herbish, A.S.; Mazrou, A.M.M.; Al Sohaibani, M.O. The Haematological Manifestations of Visceral Leishmaniasis in Infancy and Childhood. J. Trop. Pediatr. 1995, 41, 143–148. [Google Scholar] [CrossRef]
- Casero-González, M.M.; Izquierdo-Palomares, L.; Cañuelo-Ruiz, O.; Montero-Yéboles, R.; de la Torre-Aguilar, M.J.; Ruiz-Sáez, B. Splenic Nodules as Guiding Signs in Pediatric Population with Visceral Leishmaniasis. An. Pediatría 2022, 97, 65–66. [Google Scholar] [CrossRef] [PubMed]
- Levi, M.; Sivapalaratnam, S. Disseminated Intravascular Coagulation: An Update on Pathogenesis and Diagnosis. Expert Rev. Hematol. 2018, 11, 663–672. [Google Scholar] [CrossRef]
- De Santana Ferreira, E.; De Souza Júnior, V.R.; de Oliveira, J.F.S.; Costa, M.F.H.; da Conceição de Barros Correia, M.; de Sá, A.F. Rare Association of Consumptive Coagulopathy in Visceral Leishmaniasis: A Case Report. Trop. Doct. 2021, 51, 120–122. [Google Scholar] [CrossRef]
- Mishra, P.; Dixit, A.; Chatterjee, T.; Bhattacharya, M.; Bhattacharya, J.; Pankhi, D.; Mahapatra, M.; Pati, H.P.; Saxena, R.; Ved Prakash, C. Disseminated Intravascular Coagulation as an Unusual Presentation of Kala-Azar: Report of Two Cases. Scand. J. Infect. Dis. 2004, 36, 516–519. [Google Scholar] [CrossRef]
- Skinner, J.; Yankey, B.; Shelton, B.K. Hemophagocytic Lymphohistiocytosis. AACN Adv. Crit. Care 2019, 30, 151–164. [Google Scholar] [CrossRef]
- Rosado, F.G.N.; Kim, A.S. Hemophagocytic Lymphohistiocytosis. Am. J. Clin. Pathol. 2013, 139, 713–727. [Google Scholar] [CrossRef] [PubMed]
- Daher, E.F.; Lima, L.L.L.; Vieira, A.P.F.; Nascimento, L.S.; Soares, D.S.; Abreu, K.L.S.; Zuntini, K.L.C.R.; Silva Junior, G.B. Hemophagocytic Syndrome in Children with Visceral Leishmaniasis. Pediatr. Infect. Dis. J. 2015, 34, 1311–1314. [Google Scholar] [CrossRef]
- Rajagopala, S.; Dutta, U.; Chandra, K.S.P.; Bhatia, P.; Varma, N.; Kochhar, R. Visceral Leishmaniasis Associated Hemophagocytic Lymphohistiocytosis—Case Report and Systematic Review. J. Infect. 2008, 56, 381–388. [Google Scholar] [CrossRef] [PubMed]
- Diro, E.; Lynen, L.; Ritmeijer, K.; Boelaert, M.; Hailu, A.; van Griensven, J. Visceral Leishmaniasis and HIV Coinfection in East Africa. PLoS Negl. Trop. Dis. 2014, 8, e2869. [Google Scholar] [CrossRef] [PubMed]
- Scalzone, M.; Ruggiero, A.; Mastrangelo, S.; Trombatore, G.; Ridola, V.; Maurizi, P.; Riccardi, R. Hemophagocytic Lymphohistiocytosis and Visceral Leishmaniasis in Children: Case Report and Systematic Review of Literature. J. Infect. Dev. Ctries. 2016, 10, 103–108. [Google Scholar] [CrossRef] [PubMed]
- Marie-Helene Gagnaire, C.G. Jean Louis Stéphan Hemophagocytic Syndrome: A Misleading Complication of Visceral Leishmaniasis in Children—A Series of 12 Cases. Pediatrics 2000, 106, e58. [Google Scholar] [CrossRef] [PubMed]
- Das, N. Post Kala-Azar Dermal Leishmaniasis. Indian J. Deramtology 2020, 65, 450–451. [Google Scholar] [CrossRef]
- Zijlstra, D.E.; Musa, A.; Khalil, E.; Hassan, I.E.; El-Hassan, A. Post-Kala-Azar Dermal Leishmaniasis. Lancet Infect. Dis. 2003, 3, 87–98. [Google Scholar] [CrossRef]
- Libório, A.B.; Rocha, N.A.; Oliveira, M.J.C.; Franco, L.F.L.G.; Aguiar, G.B.R.; Pimentel, R.S.; Abreu, K.L.S.; Silva, G.B.; Daher, E.F. Acute Kidney Injury in Children with Visceral Leishmaniasis. Pediatr. Infect. Dis. J. 2012, 31, 451–454. [Google Scholar] [CrossRef]
- Duarte, D.B.; Lacerda, M.C.S.R.; Ribeiro, Y.J.P.; Ribeiro, M.Z.D.; Frederico, M.d.A.; Oliveira, M.J.C. Kidney Biomarkers in Tropical Infections: An Update. Pathog. Glob. Health 2020, 114, 302–308. [Google Scholar] [CrossRef]
- Akcan-Arikan, A.; Zappitelli, M.; Loftis, L.L.; Washburn, K.K.; Jefferson, L.S.; Goldstein, S.L. Modified RIFLE Criteria in Critically Ill Children with Acute Kidney Injury. Kidney Int. 2007, 71, 1028–1035. [Google Scholar] [CrossRef] [PubMed]
- Varani, S.; Ortalli, M.; Attard, L.; Vanino, E.; Gaibani, P.; Vocale, C.; Rossini, G.; Cagarelli, R.; Pierro, A.; Billi, P.; et al. Serological and Molecular Tools to Diagnose Visceral Leishmaniasis: 2-Years’ Experience of a Single Center in Northern Italy. PLoS ONE 2017, 12, e0183699. [Google Scholar] [CrossRef] [Green Version]
- van Griensven, J.; Diro, E. Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens. Infect. Dis. Clin. North Am. 2019, 33, 79–99. [Google Scholar] [CrossRef] [PubMed]
- Sundar, S.R.M. Laboratory Diagnosis of Visceral Leishmaniasis. Clin Diagn Lab Immunol. Clin. Vaccine Immunol. 2002, 9, 951–958. [Google Scholar] [CrossRef] [PubMed]
- Maurya, R.; Mehrotra, S.; Prajapati, V.K.; Nylén, S.; Sacks, D.; Sundar, S. Evaluation of Blood Agar Microtiter Plates for Culturing Leishmania Parasites to Titrate Parasite Burden in Spleen and Peripheral Blood of Patients with Visceral Leishmaniasis. J. Clin. Microbiol. 2010, 48, 1932–1934. [Google Scholar] [CrossRef] [PubMed]
- Hide, M.; Singh, R.; Kumar, B.; Bañuls, A.L.; Sundar, S. A Microculture Technique for Isolating Live Leishmania Parasites from Peripheral Blood of Visceral Leishmaniasis Patients. Acta Trop. 2007, 102, 197–200. [Google Scholar] [CrossRef]
- Gradoni, L.; López-Vélez, R.; Mokni, M. Manual on Case Management and Surveillance of the Leishmaniases in the WHO European Region 2017; WHO: Geneva, Switzerland, 2017. [Google Scholar]
- Boelaert, M.; Verdonck, K.; Menten, J.; Sunyoto, T.; van Griensven, J.; Chappuis, F.; Rijal, S. Rapid Tests for the Diagnosis of Visceral Leishmaniasis in Patients with Suspected Disease (Review). Cochrane Database Syst Rev. 2014, 2014, CD009135. [Google Scholar] [CrossRef]
- Mukhtar, M.; Abdoun, A.; Ahmed, A.E.; Ghalib, H.; Reed, S.G.; Boelaert, M.; Menten, J.; Khair, M.M.; Howard, R.F. Diagnostic Accuracy of RK28-Based Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis: A Prospective Clinical Cohort Study in Sudan. Trans. R. Soc. Trop. Med. Hyg. 2015, 109, 594–600. [Google Scholar] [CrossRef]
- Chappuis, F.; Rijal, S.; Soto, A.; Menten, J.; Boelaert, M. A Meta-Analysis of the Diagnostic Performance of the Direct Agglutination Test and RK39 Dipstick for Visceral Leishmaniasis. Br. Med. J. 2006, 333, 723–726. [Google Scholar] [CrossRef]
- De Ruiter, C.M.; Van Der Veer, C.; Leeflang, M.M.G.; Deborggraeve, S.; Lucas, C.; Adams, E.R. Molecular Tools for Diagnosis of Visceral Leishmaniasis: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J. Clin. Microbiol. 2014, 52, 3147–3155. [Google Scholar] [CrossRef]
- Adams, E.R.; Schoone, G.J.; Ageed, A.F.; El Safi, S.; Schallig, H.D.F.H. Development of a Reverse Transcriptase Loop-Mediated Isothermal Amplification (LAMP) Assay for the Sensitive Detection of Leishmania Parasites in Clinical Samples. Am. J. Trop. Med. Hyg. 2010, 82, 591–596. [Google Scholar] [CrossRef] [PubMed]
- Vallur, A.C.; Tutterrow, Y.L.; Mohamath, R.; Pattabhi, S.; Hailu, A.; Abdoun, A.O.; Ahmed, A.E.; Mukhtar, M.; Salam, M.A.; Almeida, M.L.; et al. Development and Comparative Evaluation of Two Antigen Detection Tests for Visceral Leishmaniasis. BMC Infect. Dis. 2015, 15, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ghosh, P.; Bhaskar, K.R.H.; Hossain, F.; Khan, M.A.A.; Vallur, A.C.; Duthie, M.S.; Hamano, S.; Salam, M.A.; Huda, M.M.; Khan, M.G.M.; et al. Evaluation of Diagnostic Performance of RK28 ELISA Using Urine for Diagnosis of Visceral Leishmaniasis. Parasites and Vectors 2016, 9, 383. [Google Scholar] [CrossRef] [PubMed]
- Alves, F.; Bilbe, G.; Blesson, S.; Goyal, V.; Monnerat, S.; Mowbray, C.; Ouattara, G.M.; Pécoul, B.; Rijal, S.; Rode, J.; et al. Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives. Clin. Microbiol. Rev. 2018, 31, 1–30. [Google Scholar] [CrossRef]
- Sundar, S.; Agarwal, D. Visceral Leishmaniasis—Optimum Treatment Options in Children. Pediatr. Infect. Dis. J. 2018, 37, 492–494. [Google Scholar] [CrossRef]
- Sundar, S.; Pakula, A. Chemotherapeutics of Visceral Leishmaniasis: Present and Future Developments. Methods Mol. Biol. 2019, 176, 139–148. [Google Scholar] [CrossRef]
- Sundar, S.; Chakravarty, J. Antimony Toxicity. Int. J. Environ. Res. Public Health 2010, 7, 4267–4277. [Google Scholar] [CrossRef]
- Mazire, P.; Agarwal, V.; Roy, A. Road-Map of Pre-Clinical Treatment for Visceral Leishmaniasis. Drug. Dev. Res. 2022, 83, 317–327. [Google Scholar] [CrossRef]
- Sundar, S.; More, D.K.; Singh, M.K.; Singh, V.P.; Sharma, S.; Makharia, A.; Kumar, P.C.K.; Murray, H.W. Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic. Clin. Infect. Dis. 2000, 31, 1104–1107. [Google Scholar] [CrossRef]
- Sundar, S.; Singh, O.P. Molecular Diagnosis of Visceral Leishmaniasis. Mol. Diagnosis Ther. 2018, 22, 443–457. [Google Scholar] [CrossRef]
- Kumari, D.; Perveen, S.; Sharma, R.; Singh, K. Advancement in Leishmaniasis Diagnosis and Therapeutics: An Update. Eur. J. Pharmacol. 2021, 910, 174436. [Google Scholar] [CrossRef] [PubMed]
- Sasidharan, S.; Saudagar, P. Leishmaniasis: Where Are We and Where Are We Heading? Parasitol. Res. 2021, 120, 1541–1554. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Regional Office for South-East Asia. Regional Office for South-East Asia. Regional strategic framework for elimination of kala-azar from the South-East Asia Region (2011-2015). WHO Regional Office for South-East Asia. 2012, p. 6. Available online: https://apps.who.int/iris/handle/10665/205826 (accessed on 16 September 2022).
- Bern, C.; Adler-Moore, J.; Berenguer, J.; Boelaert, M.; Den Boer, M.; Davidson, R.N.; Figueras, C.; Gradoni, L.; Kafetzis, D.A.; Ritmeijer, K.; et al. Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis. Clin. Infect. Dis. 2006, 43, 917–924. [Google Scholar] [CrossRef]
- Sundar, S.; Sinha, P.K.; Rai, M.; Verma, D.K.; Nawin, K.; Alam, S.; Chakravarty, J.; Vaillant, M.; Verma, N.; Pandey, K.; et al. Comparison of Short-Course Multidrug Treatment with Standard Therapy for Visceral Leishmaniasis in India: An Open-Label, Non-Inferiority, Randomised Controlled Trial. Lancet 2011, 377, 477–486. [Google Scholar] [CrossRef]
- Sundar, S.; Chakravarty, J.; Agarwal, D.; Rai, M.; Henry, W.; Murray, M. Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India. N. Engl. J. Med. 2010, 362, 504–512. [Google Scholar] [CrossRef] [PubMed]
- Ekram, M.R.; Amin, M.R.; Hasan, M.J.; Khan, M.A.S.; Nath, R.; Mallik, P.K.; Lister, A.; Rahman, M. Efficacy and Safety of Single-Dose Liposomal Amphotericin B in Patients with Visceral Leishmaniasis in Bangladesh: A Real-Life Experience. J. Parasit. Dis. 2021, 45, 903–911. [Google Scholar] [CrossRef]
- Alvar, J.; den Boer, M.; Dagne, D.A. Towards the Elimination of Visceral Leishmaniasis as a Public Health Problem in East Africa: Reflections on an Enhanced Control Strategy and a Call for Action. Lancet Glob Health 2021, 9, e1763–e1769. [Google Scholar] [CrossRef]
- World Health Organization. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021–2030; Mwelecele Ntuli, M., Ed.; World Health Organization: Geneva, Switzerland, 2021; ISBN 9789240010352. [Google Scholar]
- Wasunna, M.; Njenga, S.; Balasegaram, M.; Alexander, N.; Omollo, R.; Edwards, T.; Dorlo, T.P.C.; Musa, B.; Ali, M.H.S.; Elamin, M.Y.; et al. Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. PLoS Negl. Trop. Dis. 2016, 10, e0004880. [Google Scholar] [CrossRef]
- Romero, G.A.S.; Costa, D.L.; Costa, C.H.N.; de Almeida, R.P.; de Melo, E.V.; de Carvalho, S.F.G.; Rabello, A.; de Carvalho, A.L.; Sousa, A.d.Q.; Leite, R.D.; et al. Efficacy and Safety of Available Treatments for Visceral Leishmaniasis in Brazil: A Multicenter, Randomized, Open Label Trial. PLoS Negl. Trop. Dis. 2017, 11, e0005706. [Google Scholar] [CrossRef]
- Borges, M.M.; da Silva Pranchevicius, M.C.; Noronha, E.F.; Romero, G.A.S.; Carranza-Tamayo, C.O. Efficacy and Safety of Amphotericin B Deoxycholate versus N-Methylglucamine Antimoniate in Pediatric Visceral Leishmaniasis: An Open-Label, Randomized, and Controlled Pilot Trial in Brazil. Rev. Soc. Bras. Med. Trop. 2017, 50, 67–74. [Google Scholar] [CrossRef]
- Sundar, S.J. Chakravarty An Update on Pharmacotherapy for Leishmaniasis. Expert Opin. Pharmacother. 2015, 16, 237–252. [Google Scholar] [CrossRef] [PubMed]
- Syriopoulou, V.; Daikos, G.L.; Theodoridou, M.; Pavlopoulou, I.; Manolaki, A.G.; Sereti, E.; Karamboula, A.; Papathanasiou, D.; Krikos, X.; Saroglou, G. Two Doses of a Lipid Formulation of Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis. Clin. Infect. Dis. 2003, 36, 560–566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Davidson, R.N.; Wilkinson1, R.J.; Martino, L.D.; Gradoni, L.; Giacchino, R.; Russo, R.; Gaeta, G.B.; Pempinello, R.; Scott, S.; Raimondi, F.; et al. Liposomal Amphotericin B (AmBisome) in Mediterranean Visceral Leishmaniasis: A Multi-Centre Trial. Qjm 1994, 87, 75–81. [Google Scholar] [CrossRef] [PubMed]
- Davidson, R.N.; Di Martino, L.; Gradoni, L.; Giacchino, R.; Gaeta, G.B.; Pempinello, R.; Scotti, S.; Cascio, A.; Castagnola, E.; Maisto, A.; et al. Short-Course Treatment of Visceral Leishmaniasis with Liposomal Amphotericin B (AmBisome). Clin. Infect. Dis. 1996, 22, 938–943. [Google Scholar] [CrossRef]
- Adler-Moore, J.; Proffitt, R.T. AmBisome: Liposomal Formulation, Structure, Mechanism of Action and Pre-Clinical Experience. J. Antimicrob. Chemother. 2002, 49, 21–30. [Google Scholar] [CrossRef]
- Krepis, P.; Argyri, I.; Krepi, A.; Syrmou, A.; Spyridis, N.; Tsolia, M. Short-Course Regimens of Liposomal Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis in Children: An 11-Year Retrospective Study at a Tertiary Care Center. Pediatr. Infect. Dis. J. 2017, 36, 849–854. [Google Scholar] [CrossRef]
- Younis, B.M.; Osman, M.; Khalil, E.A.G.; Santoro, F.; Furini, S.; Wiggins, R.; Keding, A.; Carraro, M.; Musa, A.E.A.; Abdarahaman, M.A.A.; et al. Safety and Immunogenicity of ChAd63-KH Vaccine in Post-Kala-Azar Dermal Leishmaniasis Patients in Sudan. Mol. Ther. 2021, 29, 2366–2377. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Scarpini, S.; Dondi, A.; Totaro, C.; Biagi, C.; Melchionda, F.; Zama, D.; Pierantoni, L.; Gennari, M.; Campagna, C.; Prete, A.; et al. Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics. Microorganisms 2022, 10, 1887. https://doi.org/10.3390/microorganisms10101887
Scarpini S, Dondi A, Totaro C, Biagi C, Melchionda F, Zama D, Pierantoni L, Gennari M, Campagna C, Prete A, et al. Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics. Microorganisms. 2022; 10(10):1887. https://doi.org/10.3390/microorganisms10101887
Chicago/Turabian StyleScarpini, Sara, Arianna Dondi, Camilla Totaro, Carlotta Biagi, Fraia Melchionda, Daniele Zama, Luca Pierantoni, Monia Gennari, Cinzia Campagna, Arcangelo Prete, and et al. 2022. "Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics" Microorganisms 10, no. 10: 1887. https://doi.org/10.3390/microorganisms10101887